| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Pleura; Pneumonitis, necrotizing granulomatous from ORIGENE TECHNOLOGIES | CS603577 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Pleura; Pneumonitis, necrotizing granulomatous from ORIGENE TECHNOLOGIES | CS603578 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Pleura; Pneumonitis, necrotizing granulomatous from ORIGENE TECHNOLOGIES | CS603579 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Pleura; Tumor of pleura, desmoplastic small round cell from ORIGENE TECHNOLOGIES | CS524383 | 5x5um | ORIGENE TECHNOLOGIES |
| Human plexin A1 (PLXNA1) from ORIGENE TECHNOLOGIES | TP322057 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2A (RAD6 homolog) (UBE2A), transcript variant 1 from ORIGENE TECHNOLOGIES | TP720160 | 10 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2A (RAD6 homolog) (UBE2A), transcript variant 1 from ORIGENE TECHNOLOGIES | TP304194 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2B (RAD6 homolog) (UBE2B) from ORIGENE TECHNOLOGIES | TP303306 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2B (UBE2B) from ORIGENE TECHNOLOGIES | TP720719 | 10 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2B (UBE2B) from ORIGENE TECHNOLOGIES | TP720915 | 10 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 1 from ORIGENE TECHNOLOGIES | TP308741 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 4 from ORIGENE TECHNOLOGIES | TP300240 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 5 from ORIGENE TECHNOLOGIES | TP312704 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 4 from ORIGENE TECHNOLOGIES | TP720944 | 10 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 4 (putative) (UBE2D4) from ORIGENE TECHNOLOGIES | TP720161 | 10 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 4 (putative) (UBE2D4) from ORIGENE TECHNOLOGIES | TP302473 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) (UBE2D1) from ORIGENE TECHNOLOGIES | TP305621 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) (UBE2D2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP318795 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) (UBE2D2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP307283 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (UBE2D3), transcript variant 3 from ORIGENE TECHNOLOGIES | TP315841 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (UBE2D3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP307371 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (UBE2D3), transcript variant 9 from ORIGENE TECHNOLOGIES | TP318977 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (UBE2D3), transcript variant 2 from ORIGENE TECHNOLOGIES | TP313585 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (UBE2D3), transcript variant 5 from ORIGENE TECHNOLOGIES | TP313686 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 1 (UBE2D1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP721188 | 50 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (UBE2E2) from ORIGENE TECHNOLOGIES | TP304787 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ubiquitin-conjugating enzyme E2D 3 (UBE2D3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP721151 | 50 ug | ORIGENE TECHNOLOGIES |
| Human LMBR1 domain containing 1 (LMBRD1) from ORIGENE TECHNOLOGIES | TP307958 | 20 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic elongation factor-2 kinase (EEF2K) from ORIGENE TECHNOLOGIES | LY402241 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic elongation factor, selenocysteine-tRNA-specific (EEFSEC) from ORIGENE TECHNOLOGIES | LY411869 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuro-oncological ventral antigen 2 (NOVA2) from ORIGENE TECHNOLOGIES | LY419278 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuro-oncological ventral antigen 1 (NOVA1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400898 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuro-oncological ventral antigen 1 (NOVA1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429301 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuro-oncological ventral antigen 1 (NOVA1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416609 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation elongation factor 1 epsilon 1 (EEF1E1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418096 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation elongation factor 1 gamma (EEF1G) from ORIGENE TECHNOLOGIES | LY419955 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 1A domain containing (EIF1AD) from ORIGENE TECHNOLOGIES | LY410201 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4A1 (EIF4A1) from ORIGENE TECHNOLOGIES | LY400547 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4A2 (EIF4A2) from ORIGENE TECHNOLOGIES | LY400722 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5A2 (EIF5A2) from ORIGENE TECHNOLOGIES | LY412495 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5A (EIF5A), transcript variant B from ORIGENE TECHNOLOGIES | LY419616 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5A (EIF5A), transcript variant D from ORIGENE TECHNOLOGIES | LY428327 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4A, isoform 3 (EIF4A3) from ORIGENE TECHNOLOGIES | LY402368 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5A (EIF5A), transcript variant C from ORIGENE TECHNOLOGIES | LY428326 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2A, 65kDa (EIF2A) from ORIGENE TECHNOLOGIES | LY410358 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3) from ORIGENE TECHNOLOGIES | LY417724 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5A-like 1 (EIF5AL1) from ORIGENE TECHNOLOGIES | LY420500 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2-alpha kinase 2 (EIF2AK2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400976 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2-alpha kinase 2 (EIF2AK2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427651 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2-alpha kinase 2 (EIF2AK2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427650 | 100 ug | ORIGENE TECHNOLOGIES |